Home » Topics » Regulatory » Patents

Patents
RSS

TK inhibitors disclosed by RCT

Feb. 14, 1997

BASF prepares dolastatin derivatives

Feb. 14, 1997

Zeneca describes ET antagonists

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Neutrophil-stimulating peptides derived from TNF described by Peptech

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...